Yayınlar & Eserler

Yayın Ağı
Makaleler 111
Tümü (111)
SCI-E, SSCI, AHCI (98)
SCI-E, SSCI, AHCI, ESCI (102)
ESCI (4)
Scopus (106)
TRDizin (21)
Diğer Yayınlar (4)

1. Letter to the Editor: A Rare Case of Upper Gastrointestinal Bleeding due to Amyloidosis

KARATAŞ A., KANDEMİR H., BİLİCAN G., CİNDORUK M., KARAKAN T.
TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.36, sa.10, 2025 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

2. The Relationship Between FIB-4 Score and Dynapenia in Older Adults

Kilic G., Karataş A., Cindoruk M., Karakan T., Kirman D., Demir B., et al.
DIAGNOSTICS , cilt.15, sa.18, ss.2323, 2025 (SCI-Expanded, Scopus) identifier

3. Intestinal Ultrasound: Advancing Towards Broader Adoption—Insights from a National Survey in Turkey

BİLİCAN G., KARAKAN T., EĞRİTAŞ GÜRKAN Ö., CİNDORUK M., Hedin C., Sabhan H., et al.
Journal of Clinical Medicine , cilt.14, sa.14, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

4. Risk factors associated with adenocarcinoma development in gastric neuroendocrine tumors: A multicenter 10-year follow-up study

KALKAN Ç., Acehan F., Atay A., KARATAŞ A., Aksoy E., Kenarli K., et al.
JOURNAL OF INVESTIGATIVE MEDICINE , 2025 (SCI-Expanded, Scopus) identifier identifier

5. The EXTENT Study: Results From an International Expert Delphi Consensus to Define Ultrasonographic Parameters for Measuring Bowel Damage in Crohn's Disease

Palmela C., Torres J., Frias-Gomes C., Allocca M., Buisson A., Colombel J., et al.
Clinical Gastroenterology and Hepatology , 2025 (SCI-Expanded, Scopus) identifier identifier

6. Experience with Ustekinumab and Vedolizumab in Inflammatory Bowel Disease Patients: Single-Center Data

Kandemir H., KARATAŞ A., Moral K., BİLİCAN G., KEKİLLİ M., CİNDORUK M., et al.
JOURNAL OF CROHNS & COLITIS , cilt.19, 2025 (SCI-Expanded, Scopus) identifier

7. Advancing intestinal ultrasound for IBD in Turkey: results of a national survey

BİLİCAN G., KARAKAN T., EĞRİTAŞ GÜRKAN Ö., Sabhan H., Hedin C., Forss A., et al.
JOURNAL OF CROHNS & COLITIS , cilt.19, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

8. Surgical treatment of portal hypertension. Analysis of 116 consecutive cases

Dalgıç A., Sarı S., Sözen M. H., Eğritaş Gürkan Ö., Öztürk H., Kozan R., et al.
TRANSPLANTATION , cilt.108, sa.9, ss.655, 2024 (SCI-Expanded, Scopus) Creative Commons License identifier

9. Effect of Ramadan Fasting on Intestinal Microbiota and Fatty Acid Binding Protein 4 in Overweight and Obese Individuals

Selen H., Seylam-Küșümler A., KARAKAN T., Moral K.
Journal of Gastrointestinal and Liver Diseases , cilt.33, sa.3, ss.330-338, 2024 (SCI-Expanded, Scopus) identifier identifier

10. Prophylactic versus endoscopy-driven treatment of crohn's postoperative recurrence: A retrospective, multicentric, european study [porcse study]

Geldof J., Truyens M., Hanssens M., Van Gucht E., Holvoet T., Elorza A., et al.
Journal of Crohn's and Colitis , cilt.18, sa.8, ss.1202-1214, 2024 (SCI-Expanded, Scopus) identifier identifier

11. World Gastroenterology Organisation Global Guidelines: Probiotics and Prebiotics

Guarner F., Sanders M. E., Szajewska H., Cohen H., Eliakim R., Herrera-deGuise C., et al.
Journal of clinical gastroenterology , cilt.58, sa.6, ss.533-553, 2024 (SCI-Expanded, Scopus) identifier identifier

12. Assessment of Knowledge and Attitudes of Physicians and Pharmacists on Probiotics: A Cross-Sectional Survey

Başar Güneş H., Bayraktar Ekincioğlu A., KARAKAN T., Demirkan K.
Turkish Journal of Pharmaceutical Sciences , cilt.21, sa.1, ss.36-41, 2024 (ESCI, Scopus, TRDizin) Creative Commons License identifier identifier

13. Compliance with Anti-TNF Alpha Treatment and Quality of Life of Inflammatory Bowel Patients: A Descriptive and Correlational Study

Ozturk E. S., Ucan S., KARAKAN T.
JOURNAL OF CROHNS & COLITIS , cilt.18, 2024 (SCI-Expanded, Scopus) identifier

14. The influence of bowel urgency on the quality of life in individuals with ulcerative colitis

KARAKAN T., Dede A., Ozgul S., Karatas A., Cindoruk M.
JOURNAL OF CROHNS & COLITIS , cilt.18, 2024 (SCI-Expanded, Scopus) identifier

15. Association between visceral adipose tissue and disease duration, clinical activity, and response to various biological agents in inflammatory bowel disease

KARAKAN T., Coskun M., Bilican G., Demir B., Karatas A., Ekmen N., et al.
JOURNAL OF CROHNS & COLITIS , cilt.18, 2024 (SCI-Expanded, Scopus) identifier

16. Determination of oral and gut mucosal microbiome profiles of patients with treatment-naive ulcerative colitis

Karakan T., Ozmeric N., Unsal B., İşler S. Ç., Akca G., Soysal F., et al.
JOURNAL OF CROHNS & COLITIS , cilt.18, 2024 (SCI-Expanded, Scopus) identifier

17. A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease

Romero-Gómez M., Lawitz E., Shankar R. R., Chaudhri E., Liu J., Lam R. L., et al.
Journal of Hepatology , cilt.79, sa.4, ss.888-897, 2023 (SCI-Expanded, Scopus) identifier identifier

18. Effect of COVID-19 Pandemic on Hepatocellular Carcinoma Diagnosis: Results from a Single Turkey Center Study

BİLİCAN G., ÖZGÜL S., EKMEN N., Moral K., KÜÇÜK H., DUMANLI S., et al.
Journal of gastrointestinal and liver diseases : JGLD , cilt.32, sa.3, ss.367-370, 2023 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

19. TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease

YILMAZ Y., ZEYBEL M., ADALI G., COŞAR A., SERTESEN E., SÜMER H., et al.
Hepatology forum , cilt.4, sa.1, ss.1-32, 2023 (ESCI, Scopus, TRDizin) Creative Commons License identifier identifier identifier identifier

20. 2D Shear Wave Elastography as novel tool for the assessment of disease severity in patients with IBD

DEMİR E., CİNDORUK M., KARATAŞ A., KARAKAN T., Kilic G., Ergin M., et al.
JOURNAL OF CROHNS & COLITIS , cilt.17, 2023 (SCI-Expanded, Scopus) identifier

21. Artificial intelligence-based personalized diet: A pilot clinical study for irritable bowel syndrome

KARAKAN T., GÜNDOĞDU A., Alagozlu H., EKMEN N., ÖZGÜL S., Tunali V., et al.
GUT MICROBES , cilt.14, sa.1, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

22. Risk of Malignancy Using the Diagnostic Categories Proposed by the World Health Organization International System for Reporting Pancreaticobiliary Cytopathology.

Gocun P. U., Simsek B., Ekinci O., Ekmen N., Arhan M., Karakan T., et al.
Acta cytologica , cilt.66, sa.6, ss.475-485, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

23. Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials

Rubin D. T., Dotan I., DuVall A., Bouhnik Y., Radford-Smith G., Mishkin D. S., et al.
The Lancet Gastroenterology and Hepatology , cilt.7, sa.1, ss.17-27, 2022 (SCI-Expanded, Scopus) identifier identifier identifier identifier

24. Changes in intestinal parameters and their association with dietary patterns in rotational shift workers

MORTAŞ H., BİLİCİ S., ÖZTÜRK H., KARAKAN T.
CHRONOBIOLOGY INTERNATIONAL , cilt.39, sa.6, ss.872-885, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

25. World Gastroenterology Organisation Global Guidelines Diet and the Gut

Makharia G., Gibson P. R., Bai J. C., KARAKAN T., Lee Y. Y., Collins L., et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY , cilt.56, sa.1, ss.1-15, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

26. Strain-specific and outcome-specific efficacy of probiotics for the treatment of irritable bowel syndrome: A systematic review and meta-analysis

Mcfarland L., Karakan T., Karataş A.
ECLINICALMEDICINE , cilt.41, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

27. Low-Dose Lactulose as a Prebiotic for Improved Gut Health and Enhanced Mineral Absorption

KARAKAN T., Tuohy K. M., Janssen-van Solingen G.
FRONTIERS IN NUTRITION , cilt.8, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

28. Gut-Brain-Microbiota Axis: Antibiotics and Functional Gastrointestinal Disorders.

KARAKAN T., ÖZKUL KOÇAK C., Kupeli Akkol E., BİLİCİ S., Sobarzo-Sanchez E., Capasso R.
Nutrients , cilt.13, sa.2, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

29. Succinivibrionaceae is dominant family in fecal microbiota of Behcet's Syndrome patients with uveitis

Tecer D., Gogus F. N., Kalkancı A., Erdogan M., Hasanreisoglu M., Ergin Ç., et al.
PLOS ONE , cilt.15, sa.10, 2020 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

30. The circadian disruption of night work alters gut microbiota consistent with elevated risk for future metabolic and gastrointestinal pathology

Mortaş H., Bilici S., Karakan T.
CHRONOBIOLOGY INTERNATIONAL , cilt.37, ss.1067-1081, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

31. Trimebutine Maleate Monotherapy for Functional Dyspepsia: A Multicenter, Randomized, Double-Blind Placebo Controlled Prospective Trial

Kountouras J., Gavalas E., Papaefthymiou A., Tsechelidis I., Polyzos S. A., BOR S., et al.
MEDICINA-LITHUANIA , cilt.56, sa.7, 2020 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

32. Structural changes in gut microbiome after Ramadan fasting: a pilot study

Ozkul C., Yalinay M., Karakan T.
BENEFICIAL MICROBES , cilt.11, sa.3, ss.227-233, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

33. The Predictive Value of Inflammatory Markers in the First Year of Diagnosis in Ulcerative Colitis

Sadioglu R. E., KARAKAN T.
GAZI MEDICAL JOURNAL , cilt.31, sa.2, ss.163-168, 2020 (ESCI, Scopus) Creative Commons License identifier identifier

34. Islamic fasting leads to an increased abundance of Akkermansia muciniphila and Bacteroides fragilis group: A preliminary study on intermittent fasting

ÖZKUL KOÇAK C., Yalinay M., KARAKAN T.
TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.30, sa.12, ss.1030-1035, 2019 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier

35. Intermittent fasting and gut microbiota

KARAKAN T.
TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.30, sa.12, ss.1008, 2019 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier

36. İntrabdominal Sepsisli Hastalarda Serum Adiponektin Sevıyeleri İle Proinflamatuar Sitokin Düzeyleri, Apache-II Skorları ve Mortalite Arasındaki İlişki

DİKMEN K., YILMAZ T. U., KEREM M., BOSTANCI H., UĞRAŞ DİKMEN A., PAŞAOĞLU Ö. T., et al.
Acıbadem Sağlık Bilimleri Dergisi , cilt.10, sa.2, ss.288-294, 2019 (TRDizin)

37. Can pancreatic steatosis affect exocrine functions of pancreas?

TAHTACI M., ALGIN O., KARAKAN T., TAYFUR YÜREKLİ Ö., Alisik M., Koseoglu H., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.29, sa.5, ss.588-594, 2018 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier

38. Bismuth-based quadruple Helicobacter pylori eradication regimen alters the composition of gut microbiota

Yildiz S. S., YALINAY A. M., KARAKAN T.
Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive , cilt.26, sa.2, ss.115-121, 2018 (Scopus) identifier identifier

39. Use of Proton Pump Inhibitors and risk of gastric cancer

KARAKAN T.
TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.29, sa.1, ss.143-144, 2018 (SCI-Expanded, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

40. Determination of certain bacterial groups in gut microbiota and endotoxin levels in patients with nonalcoholic steatohepatitis

ÖZKUL KOÇAK C., Yalinay M., KARAKAN T., Yilmaz G.
TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.28, sa.5, ss.361-369, 2017 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

41. Fecal microbiota transplantation for treating recurrent hepatic encephalopathy: Ready for clinical application?

KARAKAN T.
TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.28, sa.5, ss.425-426, 2017 (SCI-Expanded, Scopus, TRDizin) identifier

42. efficacy and safety of saccharomyces boulardii in the 14 day triple anti helicobacter pylori therapy

CİNDORUK M., KARAKAN T., ÜNAL S.
Helicobacter , 2017 (SCI-Expanded, Scopus)

43. European Crohn's and Colitis Organisation Topical Review on Environmental Factors in IBD

Maaser C., Langholz E., Gordon H., Burisch J., Ellul P., Ramirez V. H., et al.
JOURNAL OF CROHNS & COLITIS , cilt.11, sa.8, ss.905-920, 2017 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

44. A Single Center Treatment Experience in Autoimmune Hepatitis Patients

SÜTCÜOĞLU O., Sargin Z. G., Haghighi N. A., Yuceldi S. D., Karatas A., Onal I. K., et al.
GAZI MEDICAL JOURNAL , cilt.28, sa.3, ss.174-178, 2017 (ESCI, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

45. Determination of probiotic concept product consumption among people of ages 14-65

KAYA P. S., KARAKAN T., Sezgin S., AYDIN AVCİ İ., Arusoglu G.
PROGRESS IN NUTRITION , cilt.18, sa.2, ss.111-117, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

46. The prevalance of autoimmune hepatitis in hashimato thyroiditis in a turkish population

YETKİN İ., CİNDORUK M., KARAKAN T., kandilci u.
ACTA GASTRO ENTEROLOGICA BELGICA , 2016 (Hakemsiz Dergi) Sürdürülebilir Kalkınma

47. EUS versus endoscopic retrograde cholangiography for patients with intermediate probality of bile duct stones a prospective randomized trial

KARAKAN T., CİNDORUK M., alagözlü h., ergun m., DUMLU G. Ş., ÜNAL S.
Gastrointestinal Endoscopy , 2016 (SCI-Expanded, Scopus)

48. comparison of early enteral nutrition in severe acute pancreatitis with probiotic fiber supplementation versus standard enteral solution

KARAKAN T., CİNDORUK M., ÜNAL S.
world journal of gastroenterology , 2016 (SCI-Expanded, Scopus)

49. The efficacy of a through-the-scope sodium phosphate solution with completion colonoscopy on the same day as a salvage option for inadequate bowel cleansing

İBİŞ M., Onal I. K., ARHAN M., KARAKAN T., Karatay E., Utku O. G., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.46, sa.4, ss.1089-1093, 2016 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

50. Pancreatic metastasis in a case of small cell lung carcinoma diagnosed by EUS

KARAKAN T., Cengiz M., İBİŞ M., AKYÜREK N., Unal S.
TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.26, sa.1, ss.53-55, 2015 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier

51. Increased Resistin Levels in Intra abdominal Sepsis Correlation with proinflammatory cytokines and Acute Physiology and Chronic Health Evaluation APACHE II scores

YILMAZ T. U., KEREM M., YILMAZ-DEMİRTAŞ C., PAŞAOĞLU Ö. T., TAŞÇILAR Ö., ŞAKRAK Ö., et al.
SULTAN QABOOS UNIVERSITY MEDICAL SCIENCES JOURNAL , cilt.14, sa.4, ss.506-512, 2014 (Hakemli Dergi)

52. Long-term antibiotics and PPIs induce bacterial translocation in patients with cirrhosis: Antibiotics are not always ANTI-biotics

KARAKAN T.
Turkish Journal of Gastroenterology , cilt.25, sa.4, ss.472, 2014 (SCI-Expanded, Scopus, TRDizin) identifier identifier

53. Analysis of risk factors associated with complications of colonic stenting for malignant obstruction

Dindar G., ÜSTÜNDAĞ Y., KARAKAN T.
WORLD JOURNAL OF GASTROENTEROLOGY , cilt.20, sa.27, ss.9215-9216, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

54. Fecal microbiota transplant in immunocompromised patients: Encouraging results in a vulnarable population

Karakan T.
TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.25, sa.3, ss.346, 2014 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier

55. International Multidisciplinary Classification of Acute Pancreatitis Severity: The 2013 Spanish Edition Clasificación Internacional y Multidisciplinaria de la Pancreatitis Aguda: Edición española 2013

Patchen Dellinger E., Forsmark C., Lévy P., Shimosegawa T., Windsor J., Petrov M., et al.
Medicina Intensiva , cilt.38, sa.4, ss.211-217, 2014 (SCI-Expanded, Scopus) identifier identifier

56. Gut microbiota modulation in cirrhosis: A new frontier in hepatology

Karakan T.
TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.25, sa.1, ss.126, 2014 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier

57. Primary Squamous Cell Carcinoma of the Stomach: A Case Report

Tonyali O., Benekli M., KARAKAN T., KEREM M., DURSUN A., Coskun U., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.24, sa.3, ss.219-220, 2014 (SCI-Expanded, Scopus, TRDizin) identifier identifier

58. Comparison of double balloon enteroscopy in adults and children

EĞRİTAŞ GÜRKAN Ö., KARAKAN T., DOĞAN İ., DALGIÇ B., Unal S.
WORLD JOURNAL OF GASTROENTEROLOGY , cilt.19, sa.29, ss.4726-4731, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

59. Determinant-Based Classification of Acute Pancreatitis Severity International Multidisciplinary Classification of Acute Pancreatitis Severity: The 2013 German Edition

Dellinger E. P., Forsmark C. E., Levy P., Petrov M. S., Shimosegawa T., Siriwardena A. K., et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE , sa.6, ss.544-550, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

60. Biodegradable stents for caustic esophageal strictures: a new therapeutic approach

Karakan T., Utku O. G., Dorukoz O., Sen I., Colak B., Erdal H., et al.
DISEASES OF THE ESOPHAGUS , cilt.26, sa.3, ss.319-322, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

61. PPAR alpha agonist treatment increases trefoil factor fam ly 3 expression and attenuates apoptosis in the liver tissue of bile duct ligated rats

ENGİN E. D., KEREM M., KARAKAN T., CİNDORUK M.
Turkish Journal Of Gastroenterology , 2013 (SCI-Expanded, Scopus, TRDizin)

62. PPAR-alpha agonist treatment increases trefoil factor family-3 expression and attenuates apoptosis in the liver tissue of bile duct-ligated rats

KARAKAN T., KEREM M., CİNDORUK M., Engin D., Alper M., Akin O.
TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.24, sa.2, ss.134-140, 2013 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier

63. Significance of Proton Pump Inhibitor Types for Clostridium difficile Infection

ALAGÖZLÜ H., KARAKAN T.
JOURNAL OF CLINICAL GASTROENTEROLOGY , cilt.47, sa.3, ss.290, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

64. SYNBIOTIC THERAPY INCREASES ERADICATION RATE IN HELICOBACTER PYLORI ERADICATION

Sahin O., Yesil A., Senates E., Akdogan M. F., Konur S., Erdem E., et al.
ACTA MEDICA MEDITERRANEA , cilt.29, sa.3, ss.569-573, 2013 (SCI-Expanded, Scopus) identifier identifier

65. Determinant-based classification of acute pancreatitis severity: An international multidisciplinary consultation

Dellinger E. P., Forsmark C. E., Layer P., Lévy P., Petrov M. S., Shimosegawa T., et al.
Annals of Surgery , cilt.256, sa.6, ss.875-880, 2012 (SCI-Expanded, Scopus) identifier identifier

66. Current endoscopic approach to indeterminate biliary strictures

Victor D. W., Sherman S., KARAKAN T., Khashab M. A.
WORLD JOURNAL OF GASTROENTEROLOGY , cilt.18, sa.43, ss.6197-6205, 2012 (SCI-Expanded, Scopus) identifier identifier identifier

67. Prebiotics and Low Dose Synbiotics for Severe Acute Pancreatitis: Time for a Reappraisal ?

Karakan T.
ACTA CHIRURGICA BELGICA , cilt.112, sa.5, ss.403, 2012 (SCI-Expanded, Scopus) identifier identifier identifier

68. Probiotics Are Sensitive Microorganisms: Lactobacillus Can Be Affected by Stomach Acid, Antibiotic, and Bowel Cleansing

ALAGÖZLÜ H., KARAKAN T.
DIGESTIVE DISEASES AND SCIENCES , cilt.57, sa.9, ss.2477, 2012 (SCI-Expanded, Scopus) identifier identifier identifier

69. Probiotics: Should we be more definitive in terminology?

KARAKAN T., Tahtaci M., ALAGÖZLÜ H.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , cilt.24, sa.9, ss.1115-1116, 2012 (SCI-Expanded, Scopus) identifier identifier identifier

70. World gastroenterology organisation global guidelines: Probiotics and prebiotics october 2011

Guarner F., Khan A. G., Garisch J., Eliakim R., Gangl A., Thomson A., et al.
Journal of Clinical Gastroenterology , cilt.46, sa.6, ss.468-481, 2012 (SCI-Expanded, Scopus) identifier identifier

71. Two cases of Wegener's granulomatosis with pancreatic pseudocyst treated by endoscopic ultrasonography (EUS)-guided drainage

Samn M., CİNDORUK M., KARAKAN T., Ekici E.
TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.23, sa.2, ss.175-180, 2012 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

72. A case of tuberculosis diagnosed with EUS-guided aspiration biopsy.

CİNDORUK M., Sahin M., Uyar P., KARAKAN T.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.22, sa.5, ss.555-556, 2011 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma identifier identifier identifier

73. Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors

Tonyali O., Coskun U., YILDIZ R., KARAKAN T., Demirci U., AKYÜREK N., et al.
MEDICAL ONCOLOGY , cilt.27, sa.3, ss.768-773, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

74. The role of probiotics and prebiotics in the treatment of pancreatitis

KARAKAN T.
Nutritional Therapy and Metabolism , cilt.28, sa.1, ss.1-6, 2010 (Scopus) identifier

75. EUS versus endoscopic retrograde cholangiography for patients with intermediate probability of bile duct stones: a prospective randomized trial

KARAKAN T., CİNDORUK M., Alagozlu H., Ergun M., Dumlu S., Unal S.
GASTROINTESTINAL ENDOSCOPY , cilt.69, sa.2, ss.244-252, 2009 (SCI-Expanded, Scopus) identifier identifier identifier

76. The role of liver biopsy in the workup of liver dysfunction late after SCT: is the role of iron overload underestimated?

Sucak G. T., Yegin Z. A., Oezkurt Z. N., Aki S. Z., Karakan T., Akyol G.
BONE MARROW TRANSPLANTATION , cilt.42, sa.7, ss.461-467, 2008 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

77. hypertrophic colonic tuberculosis mimicking tumuorus mass

alagözlü h., ÜNAL S., KARAKAN T., CİNDORUK M.
Colorectal Disease , 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

78. Hypertrophic colonic tuberculosis mimicking tumourous mass

Ergun M., Cindoruk M., Alagozlu H., ÜNAL S., Karakan T., Dursun A.
COLORECTAL DISEASE , cilt.10, sa.7, ss.735-736, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

79. Small-volume gallbladders and decreased motility in patients with achalasia

Alagozlu H., Unal S., KARAKAN T., CİNDORUK M., Ergun M.
JOURNAL OF CLINICAL GASTROENTEROLOGY , cilt.42, sa.2, ss.191-193, 2008 (SCI-Expanded, Scopus) identifier identifier identifier

80. Identification of Helicobacter species by 16S rDNA PCR and sequence analysis in human liver samples from patients with various etiologies of benign liver diseases

CİNDORUK M., Cirak M. Y., Unal S., KARAKAN T., Erkan G., Engin D., et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , cilt.20, sa.1, ss.33-36, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

81. Osteomalacic myopathy associated with coexisting coeliac disease and primary biliary cirrhosis.

Demirag M. D., GÖKER B., HAZNEDAROĞLU Ş., Ozturk M. A., KARAKAN T., Kuruoglu R.
Medical principles and practice : international journal of the Kuwait University, Health Science Centre , cilt.17, sa.5, ss.425-8, 2008 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

82. Identification of helicobacter species by 16s r dna pcr and sewuence analysis in human liver samples from partients with various etiologies of benign liver diseases

CİNDORUK M., cirak m., ÜNAL S., KARAKAN T., gulbanu e., ENGİN E. D., et al.
European Journal Of Gastroenterology , 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

83. Apolipoprotein e gene polymorphism in nonalcoholic fatty liver disease

Demirag M. D., Onen H. İ., Karaoguz M., Dogan İ., Karakan T., Ekmekci A., et al.
DIGESTIVE DISEASES AND SCIENCES , cilt.52, sa.12, ss.3399-3403, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

84. Peroxisome proliferators-activated alpha agonist treatment ameliorates hepatic damage in rats with obstructive jaundice: an experimental study

CİNDORUK M., KEREM M., KARAKAN T., Salman B., Akin O., Alper M., et al.
BMC GASTROENTEROLOGY , cilt.7, 2007 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

85. Association between nonalcoholic fatty liver disease and coronary artery disease

Arslan U., Tuerkoglu S., Balcioglu S., Tavil Y., Karakan T., Cengel A.
CORONARY ARTERY DISEASE , cilt.18, sa.6, ss.433-436, 2007 (SCI-Expanded, Scopus) identifier identifier identifier

86. Brucella peritonitis and leucocytoclastic vasculitis due to Brucella melitensis

DİZBAY M., HIZEL K., Kilic S., Mutluay R., Ozkan Y., KARAKAN T.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES , cilt.11, sa.4, ss.443-444, 2007 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

87. Coexistence of Mirizzi syndrome with adenomyomatosis in the gallbladder: report of a case

BEDİRLİ A., KEREM M., BOSTANCI H., KARAKAN T., Sahin T. T., AKYÜREK N.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL , cilt.6, sa.4, ss.438-441, 2007 (SCI-Expanded, Scopus) identifier identifier identifier

88. Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: A prospective randomized placebo-controlled double-blind study

Cindoruk M., Erkan G., Karakan T., Dursun A., Unal S.
HELICOBACTER , cilt.12, sa.4, ss.309-316, 2007 (SCI-Expanded, Scopus) identifier identifier identifier

89. Prevalence of IgA-antiendomysial antibody in a patient cohort with idiopathic low bone mineral density

Karakan T., Ozyemisci-Taskiran O., Gunendi Z., Atalay F., Tuncer C.
WORLD JOURNAL OF GASTROENTEROLOGY , cilt.13, sa.21, ss.2978-2982, 2007 (SCI-Expanded, Scopus) identifier identifier identifier

90. Comparison of early enteral nutrition in severe acute pancreatitis with prebiotic fiber supplementation versus standard enteral solution: a prospective randomized double-blind study.

Karakan T., Ergun M., Dogan İ., Cindoruk M., Unal S.
World journal of gastroenterology , cilt.13, sa.19, ss.2733-7, 2007 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

91. Hepatic steatosis has no impact on the outcome of treatment in patients with chronic hepatitis B infection

Cindoruk M., Karakan T., Unal S.
JOURNAL OF CLINICAL GASTROENTEROLOGY , cilt.41, sa.5, ss.513-517, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

92. Influence of H pylori on plasma ghrelin in patients without atrophic gastritis

Cindoruk M., Yetkin İ., Deger S. M., Karakan T., Kan E., Unal S.
WORLD JOURNAL OF GASTROENTEROLOGY , cilt.13, sa.10, ss.1595-1598, 2007 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

93. hepatic steatosis has no impact on the outcome of treatment in patients with chronic hepatisis b infection

CİNDORUK M., KARAKAN T., ÜNAL S.
journal of clinical gastroenterology , 2007 (SCI-Expanded, Scopus)

94. influence f h pylori on plasma ghrelin in patients without atrophic gastirts

CİNDORUK M., KARAKAN T., ÜNAL S.
world jorunal of gastroenterology , 2007 (Hakemsiz Dergi)

95. The influence of Helicobacter pylori infection on the prevalence of endoscopic erosive esophagitis.

Unal S., Karakan T., Dogan İ., Cindoruk M., Dumlu S.
Helicobacter , cilt.11, sa.6, ss.556-61, 2006 (SCI-Expanded, Scopus) identifier identifier identifier

96. Heparin and insulin in the treatment of hypertriglyceridemia-induced severe acute pancreatitis

Alagozlu H., Cindoruk M., Karakan T., Unal S.
DIGESTIVE DISEASES AND SCIENCES , cilt.51, sa.5, ss.931-933, 2006 (SCI-Expanded, Scopus) identifier identifier identifier

97. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients

Yakaryilmaz F., Gurbuz O. A., Guliter S., Mert A., Songur Y., Karakan T., et al.
RENAL FAILURE , cilt.28, sa.8, ss.729-735, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

98. Reversible edema in a male patient taking parenteral pantoprazole infusion for pyloric stenosis

Sennaroglu E., Karakan S., Kayatas M., Akdur S., Genc H., Karakan T., et al.
DIGESTIVE DISEASES AND SCIENCES , cilt.51, sa.1, ss.121-122, 2006 (SCI-Expanded, Scopus) identifier identifier identifier

99. Fibrinogen storage disease without hypofibrinogenemia associated with estrogen therapy

Simsek Z., Ekinci O., Cindoruk M., Karakan T., Degertekin B., Akyol G., et al.
BMC GASTROENTEROLOGY , cilt.5, 2005 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

100. Therapy for treatment-refractory chronic Hepatitis C virus genotype 1b infection: A retrospective analysis

Cindoruk M., Karakan T., ÜNAL S.
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL , cilt.66, sa.5, ss.451-462, 2005 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

101. Combination therapy with pegylated interferon plus ribavirin in the treatment of hepatitis C virus-related thrombocytopenia.

Karakan T., Cindoruk M., Degertekin B., Dogan İ., Sancak A., Dumlu S., et al.
Current therapeutic research, clinical and experimental , cilt.66, sa.3, ss.247-53, 2005 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

102. Acute pancreatitis complicating treatment of granulocytic sarcoma; cytosine arabinoside induced? A case report

Ceneli O., Sucak G. T., YAĞCI A. M., KARAKAN T., Isik S., HAZNEDAR R.
HAEMA , cilt.8, sa.2, ss.297-300, 2005 (Scopus) identifier

103. Evaluation of gallbladder volume and motility in non-insulin-dependent diabetes mellitus patients using real-time ultrasonography

Guliter S., Yilmaz S., Karakan T.
JOURNAL OF CLINICAL GASTROENTEROLOGY , cilt.37, sa.4, ss.288-291, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

104. Prevalence of mircoscopic colitis in patients with symptoms suggesting irritable bowel syndrome

Tuncer C., Cindoruk M., Dursun A., Karakan T.
ACTA GASTRO-ENTEROLOGICA BELGICA , cilt.66, sa.2, ss.133-136, 2003 (SCI-Expanded, Scopus) identifier

105. prevalance of microscopic colitis in patients with symptoms suggesting irritable bowel syndrome

CİNDORUK M., KARAKAN T.
acta gastro enterologica belgica , 2003 (Hakemsiz Dergi)

106. The prevalence of autoimmune hepatitis in Hashimoto's thyroiditis in a turkish population

Cindoruk M., Yetkin I., Karakan T., Kandilci U.
ACTA GASTRO-ENTEROLOGICA BELGICA , cilt.65, sa.3, ss.143-145, 2002 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

107. Increased colonic intraepithelial lymphocytes in patients with Hashimoto's thyroiditis

Cindoruk M., Tuncer C., Dursun A., Yetkin I., Karakan T., Cakir N., et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY , cilt.34, sa.3, ss.237-239, 2002 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

108. efficacy of interferon alfa and lamivudine combination therapy versus interferon alfa moontherapy in Turkish patients

KARAKAN T., CİNDORUK M.
CURRENT THERAPEUTIC RESEARCH CLINICAL AND EXPERIMENTAL , 2002 (SCI-Expanded, Scopus)

109. L-carnitine in the treatment of painful diabetic neuropathy and its effect on plasma beta-endorphin levels

Cakir N., Yetkin I., Karakoc A., Karakan T., Ayvaz G., Arslan M.
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL , cilt.61, sa.12, ss.871-876, 2000 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

110. Bilateral spontaneous perinephric hematoma: Evaluation with CT and angiography and successful conservative treatment

Sucak G., Bali M., Karakan T., Haznedar R.
NEPHRON , cilt.86, sa.2, ss.237-238, 2000 (SCI-Expanded, Scopus) identifier identifier identifier

111. The use of CA15-3 and estrogen receptor in breast cancer patients with bone metastases

KARAKAN T., GÜNEL N., AKÇALI Z., ÜNER A.
GAZI MEDICAL JOURNAL , cilt.9, sa.4, ss.149-153, 1998 (Scopus) Sürdürülebilir Kalkınma
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 23

1. İnflamatuar bağırsak hastalığı sol ventriküler deformasyonun bozulmasıyla ilişkili olabilir

ÜNLÜ S., ÖZGÜL S., YALÇIN Y., YAMAK B. A., ABATAŞ SEÇKİN P., SEÇKİN GÖBÜT Ö., et al.
1. Avrasya Kalp Yetersizliği Kongresi, 10 - 13 Ekim 2024, (Özet Bildiri)

2. Linking Periodontal Diseases and Ulcerative Colitis Through Subgingival-Gut Mucosal Microbiome

İŞLER S. Ç., ÖZMERİÇ KURTULUŞ N., ÜNSAL F. B., KARAKAN T., TÖRÜNER M., ELGÜN ÜLKAR S., et al.
40- 2024 CED-IADR Congress, cenevre, İsviçre, 12 - 14 Eylül 2024, (Özet Bildiri)

3. Compliance with Anti-TNF Alpha Treatment and Quality of Life of Inflammatory Bowel Patients: A Descriptive and Correlational Study

SÖZERİ ÖZTÜRK E., Uçan Ş., KARAKAN T.
19 th Congress of European Chrohn's and Colitis Organisation, Stockholm, İsveç, 21 - 24 Şubat 2024, cilt.18, ss.2213, (Özet Bildiri)

4. Portal Hipertansiyonun Cerrahi Tedavisi. 96 Olgunun İncelenmesi

Dalgıç A., Sözen M. H., Sarı S., Eğritaş Gürkan Ö., Kozan R., Ilgıt E. T., et al.
4. Gazi Gastroenteroloji Günleri, Ankara, Türkiye, 21 Mart 2023, ss.39-41, (Özet Bildiri) Creative Commons License

5. Portal Hipertansiyonun cerrahi tedavisi; 96 olgunun incelenmesi

DALGIÇ A., SÖZEN M. H., SARI S., EĞRİTAŞ GÜRKAN Ö., KOZAN R., ılgıt E. T., et al.
4.Gazi Gastroenteroloji Günleri, 20 Mart 2023, (Özet Bildiri)

6. İnflamatuar Bağırsak Hastalığı Olan Bireylerde Ultrasonografik Entezit Sıklığı

BATIBAY S., Abiyev A., KOÇAK ULUCAKÖY R., GÜNENDİ Z., KARAKAN T., GÖĞÜŞ F. N.
Uluslararası Katılımlı Türk Romatoloji Kongresi 2023, Türkiye, 8 - 12 Mart 2023, (Özet Bildiri) Creative Commons License

7. İnflamatuar bağırsak hastalıklarında hastalık aktivitesinin değerlendirilmesinde elastografinin yeri

Demir E., cindoruk m., Karataş A., Karakan T., kılıç g., ergin m., et al.
39. Ulusal Gastroenteroloji Haftası, 22 Kasım 2022, (Tam Metin Bildiri)

8. GLİM KRİTERLERİ KULLANILARAK İNFLAMATUVAR BARSAK HASTALARINDA MALNÜTRİSYONUN DEĞERLENDİRİLMESİ

SOYLU KOÇOĞLU S., EKMEN N., KEKİLLİ M., KARAKAN T.
23. Ulusal İç Hastalıkları Konresi, Girne, Kıbrıs (Kktc), 06 Ekim 2021, ss.53-54, (Özet Bildiri)

9. MalvanicaeensisAll. Prevents the onset of Inflammation on Acetic acid-inducedUlcerativeColitis in Rats.

KARPUZ B., AKKOL E., KARAKAN T., Haroon K., TAŞTAN H.
5th International Symposium on Phytochemicals in Medicine and Food (5-ISPMF), Çin, 25 - 30 Ağustos 2021, (Özet Bildiri)

10. ARTIFICIAL INTELLIGENCE-BASED PERSONALISED DIET: A PILOT CLINICAL STUDY FOR IBS

KARAKAN T., GÜNDOĞDU A., ALAGÖZLÜ H., EKMEN N., KILIÇ G., ÖZGÜL S., et al.
Digestive Disease Week, Amerika Birleşik Devletleri, 21 Mayıs 2021, ss.99, (Tam Metin Bildiri) identifier

11. DONOR MICROBIOTA AS A DETERMINANT FACTOR FOR RESPONSE TO FMT IN PATIENTS WITH ULCERATIVE COLITIS

KARAKAN T., KARATAŞ A.
UEG Week 2018, viyana, Avusturya, 20 Ekim 2018, (Özet Bildiri)

12. Oruç tutan bireylerde oruç öncesi ve sonrası bağırsak mikrobiyotası farklılıklarının metagenomik olarak incelenmesi

ÖZKUL KOÇAK C., YALINAY A. M., KARAKAN T.
5. Ulusal Bağırsak Mikrobiyotası ve probiyotik Kongresi, Türkiye, 11 - 14 Ekim 2018, (Tam Metin Bildiri)

13. Açlık Süreçlerini Göstermek Amacıyla Oruç Tutan Bireylerde Bağırsak Mikrobiyota Analizleri

ERDOĞDU C., KARAKAN T., YALINAY A. M.
4. Ulusal Bağırsak Mikrobiyotası ve Probiyotik Kongresi, Türkiye, 19 - 22 Ekim 2017, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

14. Bacteriome and mycobiome analysis underscore the role of fungal dybiosis in nonalcoholic steatohepatitis: Fusarium genus as a novel player?

KARAKAN T., YALINAY A. M., ERDOĞDU C.
XXXth International Workshop on Helicobacter Microbiota in Inflammation Cancer, Bordeaux, Fransa, 6 - 09 Eylül 2017, cilt.22, (Özet Bildiri)

15. FECAL MICROBIOTA IN BEHCET’xxS SYNDROME PATIENTS WITH MUCOCUTANOUS AND UVEITIS INVOLVEMENT

TECER D., GÖĞÜŞ F. N., KALKANCI A., erdoğan m., çoban s., HASANREİSOĞLU C. M., et al.
Annual European Congress of Rheumatology, 14 - 17 Haziran 2017, (Özet Bildiri)

16. Increased Akkermansia muciniphila and Bacteroides fragilis Group Abundance After Islamic Fasting

ERDOĞDU C., YALINAY A. M., KARAKAN T.
ASM Microbe, 16 - 20 Haziran 2016, (Tam Metin Bildiri)

17. Dominant Bifidobacterium and Lactobacillus Species in Patients with Non-alcoholic Fatty Liver Disease

ERDOĞDU C., YALINAY A. M., KARAKAN T.
ASM Microbe, 16 - 20 Haziran 2016, (Tam Metin Bildiri)

18. Gut Microbiota in Patients with Non-Alcoholic Fatty Liver Disease

ERDOĞDU C., YALINAY A. M., KARAKAN T.
ASM Microbe, 16 - 20 Haziran 2016, (Tam Metin Bildiri)

19. Faecal microbiota transplantation as a rescue therapy for steroid-dependent and/or non-responsive patients with ulcerative colitis: a pilot study.

KARAKAN T., İBİŞ M., CİNDORUK M., GÖK SARGIN S. Z., Alizadeh N.
Uluslararası Kongre, 16 - 19 Mart 2016, (Tam Metin Bildiri)

20. Akkermansia Muciniphila Is Decreased In Patients With Non-Alcoholic Fatty Liver Disease

KARAKAN T., Gundogdu C., Yalinaycirak M., İBİŞ M.
66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Kostarika, 13 - 17 Kasım 2015, cilt.62, (Özet Bildiri) identifier

21. Sağ hepatektomi sonrası gelişen portal ven trombozunun nadir bir sebebi: Antitrombin III eksikliği.

KEREM M., ATAK M., DİKMEN K., Karabacak H., KARAKAN T., ŞAKRAK Ö.
18. Ulusal Cerrahi Kongresi, Türkiye, 23 - 27 Mayıs 2012, (Özet Bildiri)

22. Safra Kesesinin Adenomiyomatozisi ile Mirizzi Sendromunun Birlikteliği: Olgu Sunumu

BEDİRLİ A., KEREM M., BOSTANCI H., KARAKAN T., ŞAHİN T. T., AKYÜREK N.
2. Uludağ Genel Cerrahide Güncel Yaklaşım Kongresi, Bursa, Türkiye, 8 - 11 Mart 2007, (Özet Bildiri)

23. PPAR-alpha expression in patients with viral hepatitis

Karakan T., Cindoruk M., Degertekin B., ERDEM O. A., Akyol G., ÜNAL S.
40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Paris, Fransa, 13 - 17 Nisan 2005, cilt.42, ss.180-181, (Özet Bildiri) Sürdürülebilir Kalkınma identifier
Kitaplar 1

1. Akut İshaller ve Mikrobiyota

Karataş A., Karakan T.
Bağırsak Mikrobiyotası ve Fekal Mikrobiyota Transplantasyonu, Prof. Dr. Tarkan KARAKAN, Editör, Turkiye Klinikleri Gastroenterohepatology - Special Topics Book Identity, Ankara, ss.4-8, 2019 Sürdürülebilir Kalkınma
Metrikler

Yayın

137

Yayın (WoS)

104

Yayın (Scopus)

106

Atıf (WoS)

1491

H-İndeks (WoS)

23

Atıf (Scopus)

2443

H-İndeks (Scopus)

26

Atıf (Scholar)

175

H-İndeks (Scholar)

4

Atıf (TrDizin)

1

H-İndeks (TrDizin)

1

Atıf (Diğer Toplam)

2

Proje

7

Tez Danışmanlığı

6

Açık Erişim

30
BM Sürdürülebilir Kalkınma Amaçları